Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smallpox: a potential agent of bioterrorism.

Richard J Whitley1

  • 1Department of Pediatrics, Microbiology and Medicine Children's Hospital, The University of Alabama at Birmingham, ACC 616, 1600 7th Avenue South, Birmingham, AL 35233, USA. rwhitley@peds.uab.edu

Antiviral Research
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oseltamivir drug-disease modelling in infants with influenza virus infection.

British journal of clinical pharmacology·2026
Same author

Temperature-Dependent Viral Pathogenicity: Implications for Attenuation of Viral Vaccines.

Viruses·2026
Same author

Introduction and Update: Advances in Influenza Therapeutics.

The Journal of infectious diseases·2025
Same author

Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study.

The Journal of infectious diseases·2025
Same author

Valacyclovir Pharmacokinetics in Infants With Neonatal Herpes Simplex Virus Disease.

The Pediatric infectious disease journal·2025
Same author

A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy.

Transplant infectious disease : an official journal of the Transplantation Society·2024
Same journal

Evaluation of a DIVA Compliant Trivalent Negative Marker Vaccine for Foot-and-Mouth Disease in Cattle.

Antiviral research·2026
Same journal

Nanoparticles in viral pneumonia: diagnosis, therapy, and prevention.

Antiviral research·2026
Same journal

The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.

Antiviral research·2026
Same journal

Ginsenoside Rb2-based inactivation enables a Zika vaccine that maintains pregnancy and protects offspring against virus.

Antiviral research·2026
Same journal

ITGA4 drives pathogenesis of flavivirus and inhibition of it protects mice against Japanese encephalitis virus infection.

Antiviral research·2026
Same journal

Corrigendum to "A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2" [Antivir. Res. 225 (2024) 105854].

Antiviral research·2026
See all related articles

Smallpox poses a significant bioterrorism threat due to its easy transmission and the public's lack of immunity. Development of a safer vaccine and effective antiviral drugs is crucial to mitigate this risk.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Biosecurity

Background:

  • The September 11, 2001 attacks and anthrax incidents heightened awareness of bioterrorism.
  • Smallpox is a CDC-identified 'Class A Bioterrorist Threat' due to its high transmissibility and potential for rapid spread.
  • Existing smallpox vaccines have severe adverse events, and no effective antiviral therapies are available.

Purpose of the Study:

  • To address the threat of smallpox as a bioterrorism agent.
  • To highlight the need for improved countermeasures against smallpox.

Main Methods:

  • Review of smallpox as a biological threat.
  • Assessment of current vaccine and antiviral drug limitations.

Main Results:

Related Experiment Videos

  • Smallpox is a highly contagious disease with a susceptible global population.
  • Current smallpox vaccines carry significant risks, and antiviral treatments are lacking.

Conclusions:

  • Development of a safer smallpox vaccine is essential.
  • Research into safe and effective antiviral drugs for smallpox is urgently needed.
  • Improved medical countermeasures can neutralize the threat of smallpox bioterrorism.